Locally Delivered 1% Metformin Gel in Peri-implantitis

Status Completed

Clinical Trial Summary

This study evaluates the efficacy of 1% local metformin gel in deep periimplant pockets of type 2 diabetes mellitus patients. Half of the participants will receive 1% metformin gel with manual debridement while the other half will receive a placebo with manual debridement.

Clinical Trial Description

Metformin is an oral hypoglycemic drug categorized under biguanide and are considered the most efficient agents widely used in the treatment of type 2 diabetes mellitus.The general clinical benefits observed in therapy with MF seem to be greater than expected. They induce osteoblast cells to promote early bone formation through AMP kinase (AMPK) activity. Moreover, in a recent in vitro study, MF facilitated in the proliferation of MG63 osteoblast like cells. Thus, their action in stimulating bone formation has justified their use in the treatment of perimplantitis. ;

Study Design

Related Conditions & MeSH terms

Peri-Implantitis

Clinical Trial Details

NCT number	NCT03312582
Study type	Interventional
Source	King Saud University
Contact
Status	Completed
Phase	Phase 4
Start date	March 15, 2015
Completion date	July 24, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05332327` - Comparison of the Accuracy of Different Periodontal Probes for Peri-implant Pocket Registration
Enrolling by invitation	`NCT06063876` - Experimental Peri-implant Mucositis on Implant Sites That Were Previously Treated With or Without Implantoplasty	N/A
Completed	`NCT04249024` - Peri-implantitis, Comparing Treatments 970 nm Laser and Mucosal Flap Surgery	N/A
Withdrawn	`NCT03624257` - Comparing Two Treatment Modalities of Peri-implantitis - Blue Laser (445 nm) and Conventional Flap Surgery	N/A
Completed	`NCT03018795` - Ozone Therapy as an Adjunct to the Surgical Treatment of Peri-implantitis	N/A
Completed	`NCT03157193` - Effect of Hyaluronic Acid on Perimplantitis	Phase 4
Completed	`NCT02375750` - Treatment of Peri-implantitis Lesions by Using Biomaterial	N/A
Enrolling by invitation	`NCT02575274` - Peri-Implantitis Surgical Treatment an RCT Study	Phase 2/Phase 3
Completed	`NCT04833569` - ICG-PDT, Periimplantitis, Diabetes Mellitus	Phase 1
Not yet recruiting	`NCT04337645` - Resective Surgical Treatment of Peri-implantitis.	N/A
Enrolling by invitation	`NCT06033859` - Incidence of Bleeding on Probing as an Indicator of Peri-Implant Disease Progression
Active, not recruiting	`NCT06390124` - Reconstructive Therapy of Peri-implantitis With PDGF-BB (Gem-21)	Phase 4
Enrolling by invitation	`NCT05675241` - Characterizing the Inflammation Around Dental Implants
Recruiting	`NCT04983758` - 20-year Implant Survival in Periodontally Healthy and Compromised Patients
Completed	`NCT04769609` - Reconstructive Surgical Therapy of Peri-implantitis
Not yet recruiting	`NCT04323540` - Treatment of Peri-implantitis With or Without Simultaneous Soft Tissue Augmentation	N/A
Completed	`NCT04874467` - Influence of Keratinized Mucosa on Dental Implants With Mucositis	N/A
Completed	`NCT05724706` - An Evaluation of Salivary Oxidant and Antioxidant Levels in Peri-implant Health and Disease
Completed	`NCT04559841` - Regenerative Surgical Treatment of Peri-implantitis Using Nanobone With or Without Simvastatin	N/A
Recruiting	`NCT05906810` - Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Peri-implantitis and Peri-implant Mucositis	N/A